Long-Term Neurodevelopmental Outcome of Children after in Utero Exposure to Chemotherapy
Article 2020 en
Authors
AK
Anna-Maria Korakiti
EZ
Eleni Zografos
MG
Mathilde van Gerwen
Abstract
1 min read
Pregnancy-related cancer management represents a real challenge for both the patients and the physicians. The long-term neurodevelopmental outcome of children in utero exposed to chemotherapeutic agents has only recently been addressed. This review aims to systematically integrate and highlight all existing data from the literature regarding the effect of prenatal exposure to chemotherapy on fetal brain growth and child development. All eligible studies are based on validated neurodevelopmental testing scales (e.g., Bayley Scales of Infant Development, Wechsler Preschool and Primary Scale of Intelligence) and/or well-defined questionnaires. Our systematic review including 17 studies demonstrates that no major consequences on the neurodevelopment of children after in utero exposure to anti-cancer drugs have been reported; nevertheless, longer and more thorough follow-up with large-scale multicenter prospective studies is certainly required in order to draw firm conclusions.
Dakotah Feil, Grace M. Christensen, Sarina Abrishamcar, Aneesa Vanker, Nastassja Koen, Anna Kilanowski, Nadia Hoffman, Kirsten A. Donald, Michael S. Kobor, Heather J. Zar, Dan Joseph Stein, Anke Hüls
Claire Rowcliffe, Junyu Chen, Aneesa Vanker, Nastassja Koen, Dan Joseph Stein, Meaghan J. Jones, Nicole Gladish, Michael S. Kobor, Kirsten A. Donald, Catherine J. Wedderburn, Heather J. Zar, Anke Huels
Sarina Abrishamcar, Junyu Chen, Dakotah Feil, Anna Kilanowski, Nastassja Koen, Aneesa Vanker, Kirsten A. Donald, Heather J. Zar, Dan Joseph Stein, Anke Huels
Anke Hüls, Catherine J. Wedderburn, Nynke A. Groenewold, Nicole Gladish, Meaghan J. Jones, Nastassja Koen, Julia L. MacIsaac, David Lin, Katia E. Ramadori, Michael P. Epstein, Kirsten A. Donald, Michael S. Kobor, Heather J. Zar, Dan Joseph Stein
Discussion(0)
No comments yet. Be the first to comment.